Lautman Z*, Winetraub Y*, Blacher E*, Terem I, Yu C, Chibukhchyan A, Marshel JH and de la Zerda A. (2022). Intravital 3D visualization and segmentation of murine neural networks at micron resolution Scientific Reports Scientific Reports 12, 13130.

Blacher E , Tsai C, Litichevskiy L , Shipony Z, Agbaegbu Iweka C , Schneider  KM, Chuluun B, Heller HC, Menon V, Thaiss  CA and Andreasson KI. (2021) Aging disrupts circadian gene regulation and function in macrophages. Nature Immunology 23 (2): 229-236.

Blacher E. (2021) Can microbes combat neurodegeneration? Identifying a missing link between microbiome and metabolites in ALS. Science 373 (6551): 172-173. NOSTER & Science Microbiome Grand Prize Essay.

Ben Baruch B, Mantsur E, Franco-Barraza j, Blacher E, Cukierman E and Stein R. (2020) CD38 in cancer-associated fibroblasts promotes pro-tumoral activity. Laboratory Investigation 100: 1517-1531.

Blacher E*, Bashiardes S*, Rothschild D*, Shapiro H*, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, Zabari M, Ben-Zeev Brik R, Kviatcovsky D, Zmora N, Cohen Y, Bar N, Levi I, Amar N, Mehlman T, Brandis A, Biton I, Kuperman Y, Tsoory M, Alfahel L, Harmelin A, Schwartz M, Israelson A, Arike L, Johansson M. E. V, Hansson G. C, Gotkine M, Segal E and Elinav E. (2019) Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572: 474-480. Featured in tens of general media publications and commentaries, including the BBC news, The Guardian and more.

Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, Ben-Zeev R, Lehavi-Regev D, Katz MN, Pevsner-Fischer M, Gertler A, Halpern Z, Harmelin A, Amar S, Serradas P, Grosfeld A, Shapiro H, Geiger B and Elinav E. (2018). Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science 359: 1376-1383.

Kundu P*, Blacher E*, Petresson S and Elinav E. (2017) Our gut microbiome: the evolving inner self. Cell 171: 1481-1493.

Ben Baruch B*, Blacher E*, Shwartz H, Vaknine H, Erez N and Stein R. (2018). Stromal CD38 regulates progression of primary melanoma and generation of spontaneous metastasis. Oncotarget. 9: 31797-31811.

Blacher E*, Levy M*, Tatirovsky E* and Elinav E. (2017). Microbiome-modulated metabolites at the interface of host immunity. Journal of Immunology. 98: 572-580.

Levy M*, Blacher E*, Tatirovsky* E and Elinav E. (2017). Microbiome, metabolites and host immunity. Current Opinion in Microbiology. 35: 8-15.

Pevsner-Fischer M*, Blacher E*, Tatirovsky E*, Ben-Dov IZ and Elinav E (2016) The gut microbiome and hypertension. Current Opinion in Nephrology and Hypertension. 25: 1062-4821.

Schwartz H, Blacher E, Amer M, Livneh N, Abramovitz L, Klein A, Ben-Shushan D, Sofer S, Blazquez R, Barrantes-Freer A, Muller M, Muller-Decker K, Stein R, Tsarfaty G, Satchi-Fainaro R, Umansky V, Pukrop T and Erez N. (2016) Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Research. 15: 4359-4371.

Blacher E, Dadali T, Haupenthal V. J, Grimm M. O. W, Hartmann T, Lund F. E., Stein R and Levy A. (2015). Alzheimer's disease pathology is attenuated in a CD38‐deficient mouse model. Annals of Neurology. 78: 88-103.

Blacher E, Levy A, Ben Baruch B, Green K. D, Garneau-Tsodikova S, Fridman M. and Stein R. (2015). Targeting CD38 in the tumor microenvironment; a novel approach to treat glioma. Cancer Cell and Microenvironment. 2: 1-6.

Blacher E, Ben Baruch B, Levy A, Geva N, Green K. D, Garneau-Tsodikova S, Fridman M. and Stein R. (2015). Inhibition of glioma progression by a newly discovered CD38 inhibitor. International Journal of Cancer. 136: 1422-1433.

Shaul P, Steinbuch K, Blacher E, Stein R and Fridman M. (2015). Exploring the effects of glycosylation and etherification of the side-chains of the anti-cancer drug mitoxantrone. ChemMedChem. 10: 1528-1538.

Aizman E, Blacher E, Ben-Moshe O, Kogan T, Kloog Y and Mor A. (2013). Therapeutic effect of farnesylthiosalicylic acid on adjuvant-induced arthritis in rats through suppressed release of inflammatory cytokines. Clinical and Experimental Immunology .175: 458-467.

Levy A, Blacher E, Vaknine H, Lund F. E, Stein R and Mayo L. (2012). CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages. Neuro-Oncology. 14: 1037-1049.

Lindenboim L, Blacher E, Borner C and Stein R. (2010). Regulation of stress-induced nuclear proteins' redistribution: a new function of Bax and Bak uncoupled from Bcl-x_L. Cell Death and Differentiation. 17: 346–359.